Literature DB >> 10334212

Polyethylene-glycol, a potent suppressor of azoxymethane-induced colonic aberrant crypt foci in rats.

D E Corpet1, G Parnaud.   

Abstract

Bulking fibers and high water intake may decrease colon carcinogenesis in rats, and the risk of colorectal cancer in humans. We speculated that a non-fermented polymer, polyethylene-glycol (PEG) 8000, which increases stool moisture, might protect rats against colon carcinogenesis. Thirty female F344 rats were given a single injection of azoxymethane (20 mg/kg), and 7 days later randomized to AIN76 diets containing PEG (to provide 3 g/kg body wt/day), or no PEG (control). Diets were given ad libitum for 105 days, then colon carcinogenesis was assessed by the aberrant crypt foci (ACF) test. ACF were scored blindly by a single observer. Dietary feeding of PEG almost suppressed ACF larger than one crypt, and strikingly decreased the total number of ACF per rat. PEG-fed rats had 100 times less large ACF than controls (0.8 and 83 respectively, P = 0.00001). PEG-fed rats had 20 times less total ACF than control (six and 107 ACF/rat, respectively; P < 0.0001). Two treated rats had no detectable ACF. PEG is 10 times more potent than other chemopreventive agents in this model. Since PEG is generally recognized as safe, its cancer-preventive features could be tested in humans.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10334212     DOI: 10.1093/carcin/20.5.915

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  7 in total

Review 1.  Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency.

Authors:  Denis E Corpet; Sylviane Taché
Journal:  Nutr Cancer       Date:  2002       Impact factor: 2.900

2.  Polyethylene glycol-mediated colorectal cancer chemoprevention: roles of epidermal growth factor receptor and Snail.

Authors:  Ramesh K Wali; Dhananjay P Kunte; Jennifer L Koetsier; Marc Bissonnette; Hemant K Roy
Journal:  Mol Cancer Ther       Date:  2008-09       Impact factor: 6.261

3.  Polyethylene glycol enhances colonic barrier function and ameliorates experimental colitis in rats.

Authors:  Sebastián Videla; Aurelia Lugea; Jaime Vilaseca; Francisco Guarner; Francesc Treserra; Antonio Salas; Ernesto Crespo; Carlos Medina; Juan R Malagelada
Journal:  Int J Colorectal Dis       Date:  2006-10-24       Impact factor: 2.571

4.  Polyethylene glycol, unique among laxatives, suppresses aberrant crypt foci, by elimination of cells.

Authors:  Sylviane Taché; Géraldine Parnaud; Erik Van Beek; Denis E Corpet
Journal:  Scand J Gastroenterol       Date:  2006-06       Impact factor: 2.423

5.  Higher molecular weight polyethylene glycol increases cell proliferation while improving barrier function in an in vitro colon cancer model.

Authors:  Shruthi Bharadwaj; Ramana Vishnubhotla; Sun Shan; Chinmay Chauhan; Michael Cho; Sarah C Glover
Journal:  J Biomed Biotechnol       Date:  2011-10-01

6.  Topical polyethylene glycol as a novel chemopreventive agent for oral cancer via targeting of epidermal growth factor response.

Authors:  Ramesh K Wali; Dhananjay P Kunte; Mart De La Cruz; Ashish K Tiwari; Jeffrey Brasky; Christopher R Weber; Tina P Gibson; Amir Patel; Suzana D Savkovic; Bruce E Brockstein; Hemant K Roy
Journal:  PLoS One       Date:  2012-06-04       Impact factor: 3.240

7.  Prevention of colonic neoplasia with polyethylene glycol: A short term randomized placebo-controlled double-blinded trial.

Authors:  Ramesh K Wali; Laura Bianchi; Sonia Kupfer; Mart De La Cruz; Borko Jovanovic; Christopher Weber; Michael J Goldberg; L M Rodriguez; Raymond Bergan; David Rubin; Mary Beth Tull; Ellen Richmond; Beth Parker; Seema Khan; Hemant K Roy
Journal:  PLoS One       Date:  2018-04-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.